Antisoma plc: Antisoma to present at Piper Jaffray Health Car... | Company Announcements

Wednesday 25 November, 2009

Antisoma plc

Antisoma to present at Piper Jaffray Health Car...





25  November 2009, London, UK, and Cambridge, MA: Antisoma plc (LSE:
ASM; USOTC: ATSMY) announces that its Chief Executive Officer, Glyn
Edwards, will present an overview of the Company's strategy,
programmes and prospects at the Piper Jaffray 21st Annual Health Care
Conference in New York City, on Tuesday, December 1st  at 14:30
EST/19:30 GMT.

A webcast of the presentation will be available on Antisoma's website
at 

http://www.antisoma.com/asm/media/webcast/

For live viewing of the webcast, it is recommended that viewers log
on 15 minutes early in order to register and download any necessary
software.

Enquiries
Daniel Elger
VP, Marketing and Communications
Antisoma plc
+44 (0) 20 3249 2100

Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company
that develops novel products for the treatment of cancer. The Company
has operations in the UK and the US. Please visit www.antisoma.com
for further information about Antisoma.

---END OF MESSAGE---




This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.

Investegate takes no responsibility for the accuracy of the information within the site.

The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.